Publications

Recent publications

The District Hospital.English, M. Lanata, C. F. Ngugi, I. Smith, P. C.
Disease Control Priorities in Developing Countries, (2006). :

Attitudes and practices of families and health care personnel toward children with epilepsy in Kilifi, Kenya.El Sharkawy, G. Newton, C. Hartley, S.
Epilepsy Behav, (2006). 8:201-12

Chapter 21: Conquering malaria.Breman, J. G. Mills, A. Snow RW Mulligan, J. A. Lengeler, C. Mendis, K. Sharp, B. Morel, C. Marchesini, P. White, N. J. Steketee, R. W. Doumba, O. K.
Disease Control Priorities in Developing Countries , (2006). :

Antibiotics for children with septicaemia in hospitals with limited resources..Berkley, J.A, Lowe, B.S, English, M, Scott, J.A.G,
J Trop Pediatr, (2006). 52:46-48

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.Bejon, P. Peshu, N. Gilbert, S. C. Lowe, B. S. Molyneux, C. S. Forsdyke, J. Lang, T. Hill, A. V. Marsh, K.
Clin Infect Dis, (2006). 42:1102-10

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.Bejon, P. Mwacharo, J. Kai, O. K. Todryk, S. Keating, S. Lang, T. Gilbert, S. C. Peshu, N. Marsh, K. Hill, A. V.
Vaccine, (2006). 24:4709-15

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon, P. Mwacharo, J. Kai, O. Mwangi, T. Milligan, P. Todryk, S. Keating, S. Lang, T. Lowe, B. Gikonyo, C. Molyneux, C. Fegan, G. Gilbert, S. C. Peshu, N. Marsh, K. Hill, A. V.
PLoS Clin Trials, (2006). 1:e29

Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals.Bejon, P. Keating, S. Mwacharo, J. Kai, O. K. Dunachie, S. Walther, M. Berthoud, T. Lang, T. Epstein, J. Carucci, D. Moris, P. Cohen, J. Gilbert, S. C. Peshu, N. Marsh, K. Hill, A. V.
Infect Immun, (2006). 74:6331-8

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.Bejon, P. Kai, O. K. Mwacharo, J. Keating, S. Lang, T. Gilbert, S. C. Peshu, N. Marsh, K. Hill, A. V.
Eur J Immunol, (2006). 36:2264-72

Are laboratory services coming of age in sub-Saharan Africa?.Bates, I. Maitland, K.
Clin Infect Dis, (2006). 42:383-4

In children aged 2-59 months with pneumonia, which clinical signs best predict hypoxaemia?.Ayieko, P. English, M.
J Trop Pediatr, (2006). 52:307-10

Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial.Akech, S. Gwer, S. Idro, R. Fegan, G. Eziefula, A. C. Newton, C. R. Levin, M. Maitland, K.
PLoS Clin Trials, (2006). 1:e21

The quality of sulfadoxine-pyrimethamine prescriptions, counselling and drug-dispensing practices, for children in Kenya.Zurovac, D. Ochola, S. A. Midia, B. Snow, R. W.
Ann Trop Med Parasitol, (2005). 99:321-4

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.Zurovac, D. Ndhlovu, M. Rowe, A. K. Hamer, D. H. Thea, D. M. Snow, R. W.
BMJ, (2005). 331:734

Withdrawal of parenteral phenobarbitone--implications for resource-poor countries.Wilmshurst, J. M. van Toorn, R. Newton, C. R.
S Afr Med J, (2005). 95:422-3

Withdrawal of older anticonvulsants for management of status epilepticus: implications for resource-poor countries.Wilmshurst, J. M. Newton, C. R.
Dev Med Child Neurol, (2005). 47:219

Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya.Williams, T. N. Wambua, S. Uyoga, S. Macharia, A. Mwacharo, J. K. Newton, C. R. Maitland, K.
Blood, (2005). 106:368-71

Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait.Williams, T. N. Mwangi, T. W. Wambua, S. Peto, T. E. Weatherall, D. J. Gupta, S. Recker, M. Penman, B. S. Uyoga, S. Macharia, A. Mwacharo, J. K. Snow, R. W. Marsh, K.
Nat Genet, (2005). 37:1253-7

Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases.Williams, T. N. Mwangi, T. W. Wambua, S. Alexander, N. D. Kortok, M. Snow, R. W. Marsh, K.
J Infect Dis, (2005). 192:178-86

An immune basis for malaria protection by the sickle cell trait.Williams, T. N. Mwangi, T. W. Roberts, D. J. Alexander, N. D. Weatherall, D. J. Wambua, S. Kortok, M. Snow, R. W. Marsh, K.
PLoS Med, (2005). 2:e128